Men who use Fortesta to treat low testosterone may face a significantly increased risk of heart attack and stroke, especially if they are over the age of 65. Thousands of plaintiffs are now pursing testosterone lawsuits for cardiovascular injuries they allegedly suffered due to their use of low-T therapies like Fortesta.
You may be eligible to file a Fortesta lawsuit if you or a man you love experienced any of the following complications while using this testosterone treatment:
If you would like to explore your legal options, please contact Bernstein Liebhard LLP at (888) 994-5118.
Fortesta is a topical gel marketed by Endo Pharmaceuticals that is applied to the skin on the thighs once every morning. Like other prescription testosterone treatments, Fortesta is only indicated to treat hypogonadism (low testosterone) that is related to an underlying medical condition, such as a problem with the pituitary gland or side effects of chemotherapy. The safety and efficacy of Fortesta in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
The U.S. Food & Drug Administration issued a Safety Communication in January 2014 announcing that it was reviewing Fortesta and other low-T treatments after two studies linked the drugs to an increased risk of heart attacks:
In March 2015, the FDA ordered low-T manufacturers to add new warnings to their drug labels regarding a possible association with heart attacks and strokes.
In June 2014, new blood clot warnings were added to the labels of all prescription testosterone treatments, after the FDA determined that the drugs may increase the risk for venous blood clots such as pulmonary embolism and deep vein thrombosis. Read More
You may be eligible to file a Fortesta lawsuit if you suffered a heart attack, stroke or dangerous blood clot while using this low-T treatment. To learn more about the growing testosterone litigation, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.